Cargando…

Plasma Levels of Interleukins 36α, 36β, and 37 in Patients with Psoriasis and Their Correlation with Disease Activity Parameters

Psoriasis is a chronic, proliferative, inflammatory skin disease characterised by skin lesions and systemic symptoms. Numerous cytokines are produced in psoriasis as a result of inflammation. The aim of this study was to examine the plasma concentrations of IL-36α, IL-36β, and IL-37 in psoriasis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Słucznowska-Głabowska, Sylwia, Jaworska, Weronika, Staniszewska, Marzena, Tkacz, Marta, Safranow, Krzysztof, Łuczkowska, Karolina, Zagrodnik, Edyta, Stecewicz, Iwona, Machaliński, Bogusław, Pawlik, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501264/
https://www.ncbi.nlm.nih.gov/pubmed/36142901
http://dx.doi.org/10.3390/jcm11185254
_version_ 1784795431277953024
author Słucznowska-Głabowska, Sylwia
Jaworska, Weronika
Staniszewska, Marzena
Tkacz, Marta
Safranow, Krzysztof
Łuczkowska, Karolina
Zagrodnik, Edyta
Stecewicz, Iwona
Machaliński, Bogusław
Pawlik, Andrzej
author_facet Słucznowska-Głabowska, Sylwia
Jaworska, Weronika
Staniszewska, Marzena
Tkacz, Marta
Safranow, Krzysztof
Łuczkowska, Karolina
Zagrodnik, Edyta
Stecewicz, Iwona
Machaliński, Bogusław
Pawlik, Andrzej
author_sort Słucznowska-Głabowska, Sylwia
collection PubMed
description Psoriasis is a chronic, proliferative, inflammatory skin disease characterised by skin lesions and systemic symptoms. Numerous cytokines are produced in psoriasis as a result of inflammation. The aim of this study was to examine the plasma concentrations of IL-36α, IL-36β, and IL-37 in psoriasis and their correlations with disease activity parameters. This study recruited 84 individuals, 53 with plaque-type psoriasis and 31 healthy controls. The plaque type of psoriasis is the most common type and is typically characterized by circular-to-oval red plaques distributed over body surfaces of the extremities and scalp. In patients with psoriasis, we observed statistically significantly decreased plasma concentrations of IL-36β and IL-37. The concentrations of IL-36α were increased in comparison with control group. The plasma concentrations of IL-36α and IL-36β were statistically significantly correlated with all tested parameters of disease activity: the Psoriasis Activity Severity Index, Dermatology Life Quality Index, and Body Surface Area Index. There were no statistically significant correlations between plasma levels of IL-37 and the tested parameters of disease activity. These results indicate a role of IL36α, IL-36β, and IL-37 in the pathogenesis of psoriasis.
format Online
Article
Text
id pubmed-9501264
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95012642022-09-24 Plasma Levels of Interleukins 36α, 36β, and 37 in Patients with Psoriasis and Their Correlation with Disease Activity Parameters Słucznowska-Głabowska, Sylwia Jaworska, Weronika Staniszewska, Marzena Tkacz, Marta Safranow, Krzysztof Łuczkowska, Karolina Zagrodnik, Edyta Stecewicz, Iwona Machaliński, Bogusław Pawlik, Andrzej J Clin Med Article Psoriasis is a chronic, proliferative, inflammatory skin disease characterised by skin lesions and systemic symptoms. Numerous cytokines are produced in psoriasis as a result of inflammation. The aim of this study was to examine the plasma concentrations of IL-36α, IL-36β, and IL-37 in psoriasis and their correlations with disease activity parameters. This study recruited 84 individuals, 53 with plaque-type psoriasis and 31 healthy controls. The plaque type of psoriasis is the most common type and is typically characterized by circular-to-oval red plaques distributed over body surfaces of the extremities and scalp. In patients with psoriasis, we observed statistically significantly decreased plasma concentrations of IL-36β and IL-37. The concentrations of IL-36α were increased in comparison with control group. The plasma concentrations of IL-36α and IL-36β were statistically significantly correlated with all tested parameters of disease activity: the Psoriasis Activity Severity Index, Dermatology Life Quality Index, and Body Surface Area Index. There were no statistically significant correlations between plasma levels of IL-37 and the tested parameters of disease activity. These results indicate a role of IL36α, IL-36β, and IL-37 in the pathogenesis of psoriasis. MDPI 2022-09-06 /pmc/articles/PMC9501264/ /pubmed/36142901 http://dx.doi.org/10.3390/jcm11185254 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Słucznowska-Głabowska, Sylwia
Jaworska, Weronika
Staniszewska, Marzena
Tkacz, Marta
Safranow, Krzysztof
Łuczkowska, Karolina
Zagrodnik, Edyta
Stecewicz, Iwona
Machaliński, Bogusław
Pawlik, Andrzej
Plasma Levels of Interleukins 36α, 36β, and 37 in Patients with Psoriasis and Their Correlation with Disease Activity Parameters
title Plasma Levels of Interleukins 36α, 36β, and 37 in Patients with Psoriasis and Their Correlation with Disease Activity Parameters
title_full Plasma Levels of Interleukins 36α, 36β, and 37 in Patients with Psoriasis and Their Correlation with Disease Activity Parameters
title_fullStr Plasma Levels of Interleukins 36α, 36β, and 37 in Patients with Psoriasis and Their Correlation with Disease Activity Parameters
title_full_unstemmed Plasma Levels of Interleukins 36α, 36β, and 37 in Patients with Psoriasis and Their Correlation with Disease Activity Parameters
title_short Plasma Levels of Interleukins 36α, 36β, and 37 in Patients with Psoriasis and Their Correlation with Disease Activity Parameters
title_sort plasma levels of interleukins 36α, 36β, and 37 in patients with psoriasis and their correlation with disease activity parameters
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501264/
https://www.ncbi.nlm.nih.gov/pubmed/36142901
http://dx.doi.org/10.3390/jcm11185254
work_keys_str_mv AT słucznowskagłabowskasylwia plasmalevelsofinterleukins36a36band37inpatientswithpsoriasisandtheircorrelationwithdiseaseactivityparameters
AT jaworskaweronika plasmalevelsofinterleukins36a36band37inpatientswithpsoriasisandtheircorrelationwithdiseaseactivityparameters
AT staniszewskamarzena plasmalevelsofinterleukins36a36band37inpatientswithpsoriasisandtheircorrelationwithdiseaseactivityparameters
AT tkaczmarta plasmalevelsofinterleukins36a36band37inpatientswithpsoriasisandtheircorrelationwithdiseaseactivityparameters
AT safranowkrzysztof plasmalevelsofinterleukins36a36band37inpatientswithpsoriasisandtheircorrelationwithdiseaseactivityparameters
AT łuczkowskakarolina plasmalevelsofinterleukins36a36band37inpatientswithpsoriasisandtheircorrelationwithdiseaseactivityparameters
AT zagrodnikedyta plasmalevelsofinterleukins36a36band37inpatientswithpsoriasisandtheircorrelationwithdiseaseactivityparameters
AT stecewicziwona plasmalevelsofinterleukins36a36band37inpatientswithpsoriasisandtheircorrelationwithdiseaseactivityparameters
AT machalinskibogusław plasmalevelsofinterleukins36a36band37inpatientswithpsoriasisandtheircorrelationwithdiseaseactivityparameters
AT pawlikandrzej plasmalevelsofinterleukins36a36band37inpatientswithpsoriasisandtheircorrelationwithdiseaseactivityparameters